Skip to main content
. 2024 Feb 7;17(3):e012446. doi: 10.1161/CIRCEP.123.012446

Figure 2.

Figure 2.

Trade-off plot demonstrating cost per quality adjusted life year (QALY) gained vs relative reduction in cardiac implantable electronic device (CIED) infections (%) for the whole cohort, with TYRX antimicrobial envelopes allocated according to different BLISTER and PADIT score thresholds.